NewGenIvf Group (NASDAQ:NIVF) Shares to Reverse Split on Monday, October 12th

NewGenIvf Group Limited (NASDAQ:NIVF) shares are going to reverse split on the morning of Monday, October 12th. The 1-4 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the market closes on Sunday, October 11th.

NewGenIvf Group Price Performance

NewGenIvf Group stock traded down $0.02 during mid-day trading on Thursday, hitting $0.08. The stock had a trading volume of 18,737,952 shares, compared to its average volume of 8,170,449. The stock has a 50-day simple moving average of $1.12 and a two-hundred day simple moving average of $6.93. NewGenIvf Group has a 12 month low of $0.06 and a 12 month high of $1,539.00.

NewGenIvf Group (NASDAQ:NIVF) last announced its quarterly earnings data on Wednesday, October 7th. The company reported ($13.32) earnings per share for the quarter. The business had revenue of $0.96 million during the quarter. As a group, research analysts anticipate that NewGenIvf Group will post 42.67 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of analysts have commented on the stock. Weiss Ratings reaffirmed a “sell (d)” rating on shares of NewGenIvf Group in a report on Friday, July 24th. Wall Street Zen raised NewGenIvf Group to a “hold” rating in a research note on Saturday, July 4th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, NewGenIvf Group currently has an average rating of “Sell”.

Insider Transactions at NewGenIvf Group

In other news, Director Kong Yiu Cheung bought 2,500,000 shares of the stock in a transaction on Monday, July 27th. The stock was purchased at an average price of $1.00 per share, with a total value of $2,500,000.00. Following the completion of the purchase, the director owned 3,722,223 shares of the company’s stock, valued at approximately $3,722,223. This trade represents a 204.55% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. Corporate insiders own 31.80% of the company’s stock.

NewGenIvf Group Company Profile

NewGenIvf Group Limited is a fertility-services company that provides assisted reproductive and related medical services. Through its NewGen IVF network, the company serves individuals and couples seeking fertility evaluation, in vitro fertilization (IVF), and other treatments designed to support conception.

Its services include fertility consultations and diagnostic testing, ovarian stimulation, egg retrieval, embryo transfer, intracytoplasmic sperm injection (ICSI), embryo and reproductive-cell freezing, and preimplantation genetic testing.